NIDC News

Join us at SNMMI~
Visit the DOE IP booth at the virtual SNMMI Annual Meeting
Barium-133 is available now
A limited quantity of barium-133 is now available through the DOE IP in millicurie quantities.
Funding Opportunity Announcement for Advancing Novel Medical Isotopes for Clinical Trials
 The DOE Isotope Program is excited to announce a new Funding Opportunity

DOE Isotope Program Highlights

Image courtesy of Jon Burns, Texas A&M University At-211 – ketone interaction within the chromatography column.

New Elegant Method for Rapid Recovery of Anti-Cancer Agent At-211

A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
Image courtesy of Donald Montoya, Los Alamos National Laboratory Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. These novel isotopes are being developed and produced by the DOE Isotope Program.

New Imaging Isotope Meets Promising Therapy Isotopes

New production methods for Ce-134 advance technologies for imaging human disease and guiding treatment.
Julie Ezold has been elected to a three-year term on the American Nuclear Society’s Board of Directors.

Ezold elected to the ANS Board of Directors

Julie Ezold, section head at ORNL, has been elected to a three-year term on the American Nuclear Society’s Board of Directors.
Increasing the Arsenal of Radioisotopes in the Fight Against Cancer

Increasing the Arsenal of Radioisotopes in the Fight Against Cancer

A new supply of a critical radioisotope advances personalized medicine.